Catalyst Speaking at DIA Annual Meeting in Washington, DC

Catalyst is moderating two separate panel discussions at the Drug Information Association (DIA) annual meeting. On June 17, join us for in-depth discussions on timely subjects: 21st Century Cures legislation, and Precision Medicine.

For both panels, Catalyst President Nancy Bradish Myers will host discussions with key thought leaders representing a range of stakeholders:

  • Panel 1: “21st Century Cures: Which Are the Most Transformative Provisions and How Do They Accomplish Major Change?”Panelists:
    • Janet Woodcock, CDER Director, FDA
    • Ellen Sigal, Friends of Cancer Research Founder and Chairperson
    • Clay Alspach, House Energy & Commerce Committee Chief Majority Health Counsel[gap height=”30″]
  • Panel 2: “Precision Medicine: Where Is the Technology Taking Us, How Fast and Who Is Driving?”Panelists:
    • Felix Frueh, Chief Scientific Officer, Human Longevity, Inc.
    • Robert Califf, FDA Deputy Commissioner, Medical Products and Tobacco
    • Zivana Tezak, FDA Assistant Director, Science and Technology, OIR, CDRH

Full program information is available on the DIA web site.